151 related articles for article (PubMed ID: 14659324)
1. In vivo 1H-MRS evaluation of malignant and benign breast diseases.
Kim JK; Park SH; Lee HM; Lee YH; Sung NK; Chung DS; Kim OD
Breast; 2003 Jun; 12(3):179-82. PubMed ID: 14659324
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of spectral selected press sequence in breast lesion characterization.
Lu H; Liu PF; Bao RX; Sun F
Chin Med Sci J; 2006 Dec; 21(4):265-9. PubMed ID: 17249203
[TBL] [Abstract][Full Text] [Related]
3. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
4. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil.
Gribbestad IS; Singstad TE; Nilsen G; Fjøsne HE; Engan T; Haugen OA; Rinck PA
J Magn Reson Imaging; 1998; 8(6):1191-7. PubMed ID: 9848727
[TBL] [Abstract][Full Text] [Related]
5. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions.
Ntziachristos V; Yodh AG; Schnall MD; Chance B
Neoplasia; 2002; 4(4):347-54. PubMed ID: 12082551
[TBL] [Abstract][Full Text] [Related]
6. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.
Ramazan A; Demircioglu O; Ugurlu U; Kaya H; Aribal E
Clin Imaging; 2016; 40(5):831-6. PubMed ID: 27179154
[TBL] [Abstract][Full Text] [Related]
8. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
10. In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
Bathen TF; Heldahl MG; Sitter B; Vettukattil R; Bofin A; Lundgren S; Gribbestad IS
MAGMA; 2011 Dec; 24(6):347-57. PubMed ID: 21909791
[TBL] [Abstract][Full Text] [Related]
11.
Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
[TBL] [Abstract][Full Text] [Related]
12. Aspiration biopsy of mammary lesions with abundant extracellular mucinous material. Review of 43 cases with surgical follow-up.
Ventura K; Cangiarella J; Lee I; Moreira A; Waisman J; Simsir A
Am J Clin Pathol; 2003 Aug; 120(2):194-202. PubMed ID: 12931549
[TBL] [Abstract][Full Text] [Related]
13. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
14. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
15. MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma.
Geraghty PR; van den Bosch MA; Spielman DM; Hunjan S; Birdwell RL; Fong KJ; Stables LA; Zakhour M; Herfkens RJ; Ikeda DM
Breast J; 2008; 14(6):574-80. PubMed ID: 19000051
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic application of ultrasound-guided 8-gauge Mammotome system in presumed benign breast lesions.
Luo HJ; Chen X; Tu G; Wang J; Wu CY; Yang GL
Breast J; 2011; 17(5):490-7. PubMed ID: 21762243
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic 14 gauge core-biopsy of the breast: results from 101 patients.
Frayne J; Sterrett GF; Harvey J; Goodwin P; Townsend J; Ingram D; Parsons RW
Aust N Z J Surg; 1996 Sep; 66(9):585-91. PubMed ID: 8859155
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
